Work

Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

Year: 2016

Type: article

Abstract: It is important to realize that guidelines cannot always account for individual variation among patients. They are not intended to supplant physician judgment with respect to particular patients or special clinical situations. IDSA considers adherence to these guidelines to be voluntary, with the ultimate determination regarding their application to be made by the physician in the light of each patient's individual circumstances.

Source: Clinical Infectious Diseases

DOI: 10.1093/cid/civ1194

Authors: Peter G. Pappas, Carol A. Kauffman, David R. Andes, Cornelius J. Clancy, Kieren A. Marr, Luis Ostrosky-Zeichner, Annette C. Reboli, Mindy G. Schuster, Jose A. Vazquez, Thomas J. Walsh, Theoklis E. Zaoutis, Jack D. Sobel

Institutions: University of Alabama at Birmingham, University of Michigan, VA Ann Arbor Healthcare System, Michigan Medicine, University of Wisconsin–Madison, University of Pittsburgh, Johns Hopkins University, The University of Texas Health Science Center at Houston, Cooper Medical School of Rowan University, University of Pennsylvania, Augusta University, Cornell University, Weill Cornell Medical Center, Wayne State University, Harper University Hospital

Language: English

Topic: Antifungal resistance and susceptibility

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Pfizer, Gilead Sciences, Infectious Diseases Society of America, University of Pittsburgh, CSL Behring, Cidara Therapeutics, Revolution Medicines, Astellas Pharma, National Institutes of Health, Centers for Disease Control and Prevention, Genentech

OpenAlex ID: W2260819425

FWCI: 223.7

Cites: 2

Cited by: 1,301

Related to: 10